Review Note
Last Update: 02/08/2025 09:55 PM
Current Deck: Pharm ANS exam 1
PublishedCurrently Published Content
Front
edrophonium
Back
- class: cholinomimetic
- effects:indirect acting
- AE:
- MOA: indirect acting: inhibit AChesterase and increase ACh/cholinomimetic
- Indication: diagnose myasthenia gravis
- CI:
- Route:
- effects:indirect acting
- AE:
- MOA: indirect acting: inhibit AChesterase and increase ACh/cholinomimetic
- Indication: diagnose myasthenia gravis
- CI:
- Route:
No published tags.
Pending Suggestions
No pending suggestions for this note.